ETF Managers Group’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $698K | Sell |
18,630
-1,061
| -5% | -$39.8K | 0.02% | 334 |
|
|
2022
Q4 | $944K | Buy |
19,691
+2,187
| +12% | +$105K | 0.04% | 164 |
|
|
2022
Q3 | $420K | Sell |
17,504
-919
| -5% | -$22.1K | 0.01% | 494 |
|
|
2022
Q2 | $381K | Buy |
18,423
+1,342
| +8% | +$27.8K | 0.01% | 560 |
|
|
2022
Q1 | $411K | Buy |
17,081
+1,127
| +7% | +$27.1K | 0.01% | 502 |
|
|
2021
Q4 | $406K | Sell |
15,954
-3,102
| -16% | -$78.9K | 0.01% | 548 |
|
|
2021
Q3 | $491K | Buy |
19,056
+3,901
| +26% | +$101K | 0.01% | 538 |
|
|
2021
Q2 | $342K | Sell |
15,155
-451
| -3% | -$10.2K | 0.01% | 580 |
|
|
2021
Q1 | $291K | Sell |
15,606
-9,176
| -37% | -$171K | 0.01% | 592 |
|
|
2020
Q4 | $718K | Sell |
24,782
-3,996
| -14% | -$116K | 0.02% | 277 |
|
|
2020
Q3 | $1.48M | Buy |
+28,778
| New | +$1.48M | 0.05% | 174 |
|